Pharmaceutical-care marketing strategy

Because of these changes, many multinational pharmaceutical companies include the Japanese market into their global development and marketing strategies. It is important to understand, however, that there are still many oddities for conducting clinical trial in Japan. Many of these are due to the difference in medical practice and/or attitude of the Japanese people towards effects and side effects of medicinal products, which may not harmonise with the West in a short period of time. Therefore, it is important to conduct a careful feasibility study before commencing clinical trials in Japan if global development is planned. 

To more fully understand the impact of managed care on the pharmaceutical industry, a look at managed care s cost-containment strategies and continued movement toward multiple payers will be presented first, followed by the influential market dynamics of increased competition and changing demographics. Concluding the section will be a discussion of how these factors have impacted the pharmaceutical industry s research and development priorities and product life cycles. 

In addition to the influence of a growing geriatric market segment on pharmaceutical industry research and development, each of the other managed care and market influences -cost-containment strategies, multiple payers and market competition - have collectively impacted pharmaceutical research and development. The pharmaceutical industry is highly... 

---